undamentalytics Newsletter

Smith Patrick W: insider trades

Chief executive, 10% owner at 2 companies we cover. 3 open-market purchases and 15 sales not made under a pre-set plan, reported from June 1, 2010 to February 11, 2025.

Would copying Smith Patrick W’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. After their sales, the shares moved +17.6% against the index over 12 months on average (a negative figure means selling was the right call); 33% trailed it. None of their purchases could be priced, so there is no copy portfolio.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Smith Patrick W: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 12 0.0% −4.2% 58% 7 0.57 0.59 No reliable evidence
Sales, 12 months after the report 12 +17.6% +16.2% 33% 7 1.82 0.12 No reliable evidence
Sales, 12 months after the trade 12 +16.5% +17.8% 25% 7 1.96 0.098 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Axon Enterprise AXON CHIEF EXECUTIVE OFFICER015June 1, 2010December 2, 2021
Insight Molecular Diagnostics Inc. IMDX —30December 27, 2024February 11, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 11, 2025February 7, 2025 IMDX Purchase $2,209,080 not yetnot yetnot yet
January 15, 2025January 13, 2025 IMDX Purchase $34,114 not yetnot yetnot yet
December 27, 2024December 26, 2024 IMDX Purchase $192,166 not yetnot yetnot yet
December 2, 2021November 30, 2021 AXON Sale $1,420,944 −9.5%+32.1%+18.2%
November 29, 2021November 24, 2021 AXON Sale $14,133,264 −10.8%+18.2%+17.5%
March 6, 2019March 1, 2019 AXON Sale $1,650,167 +36.2%+43.4%+38.9%
May 17, 2018May 16, 2018 AXON Sale $15,900,000 +5.2%+9.4%+18.1%
May 11, 2015May 8, 2015 AXON Sale $4,716,000 −27.9%−41.6%−41.3%
March 5, 2015March 4, 2015 AXON Sale $107,656 +40.7%−11.0%−11.0%
September 16, 2014September 15, 2014 AXON Sale $2,059,650 +33.8%+39.1%+34.0%
March 14, 2014March 12, 2014 AXON Sale $1,753,969 −29.5%+14.2%+16.6%
March 4, 2014February 28, 2014 AXON Sale $1,916,000 −37.7%−0.8%+1.7%
November 5, 2013November 1, 2013 AXON Sale $3,392,000 −4.2%−9.6%−3.0%
May 15, 2013May 13, 2013 AXON Sale $446,500 +8.1%+32.5%+34.1%
December 14, 2012December 13, 2012 AXON Sale $72,010 −4.2%+85.8%+74.2%
May 1, 2012April 30, 2012 AXON Sale $344,250 not yetnot yetnot yet
April 27, 2011April 26, 2011 AXON Sale $1,292,650 not yetnot yetnot yet
June 1, 2010May 28, 2010 AXON Sale $1,302,000 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Smith Patrick W traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.